This inventor holds 1 USPTO granted patent. Top assignees: University of Cambridge, University of Washington. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 439 
1 out of 2,173 
Years Active: 2023
Title: Innovations by Johannes Bargehr in Cardiac Treatment
Introduction
Johannes Bargehr is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of cardiac treatment through his innovative research and patents. His work focuses on enhancing cardiomyocyte maturation and engraftment, which is crucial for treating cardiac diseases.
Latest Patents
Johannes Bargehr holds a patent titled "Methods and compositions for enhancing cardiomyocyte maturation and engraftment." This patent outlines methods and compositions that include cardiomyocytes and epicardial cells aimed at treating cardiac disease. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Johannes has worked with prestigious institutions such as the University of Washington and the University of Cambridge. His research has been instrumental in developing new approaches to cardiac treatment, making him a valuable asset in the medical research community.
Collaborations
Johannes has collaborated with esteemed colleagues, including Charles E. Murry and Sanjay Sinha. These partnerships have further enriched his research and contributed to the advancement of cardiac therapies.
Conclusion
Johannes Bargehr's innovative work in cardiomyocyte maturation and engraftment represents a significant step forward in cardiac disease treatment. His contributions to the field are noteworthy and continue to inspire future research in cardiac health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile